US Artificial Intelligence (AI) in Healthcare Market (2025-2030)
The US Artificial Intelligence (AI) in Healthcare Market was valued at $8651.7 Million in 2025 and projected to reach to $43296.6 Million by 2030, representing a compound annual growth rate of CAGR: 38.0%. The US AI in healthcare market is poised for exceptional growth through 2030, driven by regulatory support, substantial healthcare IT investments, and widespread adoption across major hospital networks and health systems.
US Artificial Intelligence (AI) in Healthcare Market Trends and Insights
- The US healthcare sector is increasingly adopting AI-driven solutions for diagnostic imaging, clinical decision support, drug discovery, and administrative automation.
- This growth reflects the US healthcare industry's commitment to leveraging advanced technologies to improve patient outcomes, reduce operational costs, and address workforce shortages across hospitals, clinics, and research institutions. Driving the US market's robust 38.6% compound annual growth rate are regulatory support, substantial R&D investments, and the presence of leading technology and healthcare companies.
- The US maintains a competitive advantage through its innovation ecosystem, access to capital, and early adoption of emerging AI applications in precision medicine and personalized treatment planning.
- Between 2025 and 2030, the US is expected to consolidate its position as a global leader in AI-enabled healthcare transformation, with increasing integration across electronic health records, telemedicine platforms, and predictive analytics..
Key Market Statistics
- CAGR (2025-2030) CAGR: 38.0%
- Market Size, 2025 ~USD 8651.7 Million
- Forecast, 2030 ~USD 43296.6 Million
- Country US
US Artificial Intelligence (AI) in Healthcare Market Overview
Market Valuation Growth :
The US AI in healthcare market is valued at $8.65 billion in 2025 and is projected to reach $43.30 billion by 2030, representing a robust 38.0% CAGR driven by increased adoption of AI-powered diagnostic and administrative solutions.
Diagnostic Imaging Leadership :
US healthcare providers are rapidly deploying AI solutions for diagnostic imaging, including radiology and pathology analysis, enabling faster and more accurate disease detection while reducing radiologist workload and improving patient outcomes.
Clinical Decision Support Expansion :
US hospitals and health systems are integrating AI-driven clinical decision support systems to enhance physician decision-making, reduce medical errors, and optimize treatment protocols across various specialties and care settings.
Drug Discovery Acceleration :
US pharmaceutical and biotech companies are leveraging AI algorithms to accelerate drug discovery and development processes, reducing time-to-market and R&D costs while improving success rates in clinical trials and personalized medicine applications.
US Artificial Intelligence (AI) in Healthcare Market Dynamics
- Increasing pressure to reduce healthcare costs, improve patient outcomes, and address physician burnout is accelerating AI implementation in clinical workflows, administrative operations, and research initiatives.
- The US market benefits from advanced healthcare infrastructure, strong venture capital funding, and leading technology companies entering the healthcare sector.
- Regulatory frameworks like FDA guidance on AI/ML-based software are becoming clearer, reducing implementation barriers and encouraging enterprise-wide deployments across diverse healthcare organizations..
Related Ecosystem
Diagnostic Imaging
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- CT Scanners
- Nuclear Imaging
- Positron Emission Tomography
- Siemens healthineers
- PHILIPS HEALTHCARE
- CANON INC.
- FUJIFILM Holdings Corporation
- UNITED IMAGING HEALTHCARE CO., LTD.
Healthcare Analytics
- Machine Learning
- Natural Language Processing (NLP)
- Blood Pressure Monitors
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Oracle Corporation
- PHILIPS HEALTHCARE
- Siemens healthineers
- Zensar Technologies Limited
- EPIC SYSTEMS CORPORATION
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- The US AI in healthcare market will grow from $21.63B (2025) to $110.61B (2030), representing a 38.6% CAGR.
- The US healthcare industry is prioritizing AI adoption for diagnostic imaging, clinical decision support, and operational efficiency.
- Regulatory frameworks and substantial venture capital funding position the US as the global leader in AI healthcare innovation.
- The US market will see accelerated integration of AI across EHRs, telemedicine, and precision medicine applications by 2030.
Artificial Intelligence (AI) in Healthcare Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Forecast Period | 2025–2039 |
| Growth Rate | CAGR of 38.6% from 2025 to 2039 |
| Market Size Base Year (Billions) | ~USD 21.63 (2025) |
| Revenue Forecast (Billions) | ~USD 110.61 (2039) |
| Segments Covered | Offering, Function, Type, Technology, Application, Modality, Deployment Model, Tool, End User |
US Artificial Intelligence (AI) in Healthcare Market Report Segmentation
9 segment dimensions are covered across the global market.
By Offering
- AI Technologies
- Integrated Solutions
- Niche/Point Solutions
- Services
By Function
- Administrative
- Data Management & Analytics
- Diagnosis & Early Detection
- Patient Engagement & Remote Monitoring
- Pharmacy Management
- Post-Treatment Surveillance & Survivorship Care
- Treatment Planning & Personalization
By Type
- Ambulatory Care Centers
- Asset Management
- Auto Coding
- Behavioral Therapy & Psychotherapy
- Billing & Claims Management
- Classification & Categorization
- Compliance & Documentation
- Convolutional Neural Networks (Cnn)
- Customer Relationship Management
- Cybersecurity
- Deep Learning
- Device Context
- Diagnostic & Imaging Centers
- Diagnostic Imaging
- Diagnostics Imaging
- Dosing & Administration
- Drug Allergy Alerting
- Drug Response Prediction
- Eprescribing
- Follow-Up & Long-Term Support
- Fraud Detection & Risk Management
- Generative Adversarial Networks (Gan)
- Graph Neural Networks (Gnn)
- Healthcare Assistance Robots
- Healthcare Workflow Management
- Home Healthcare Agencies & Assisted Living Facilities
- Hospitals & Clinics
- Immunotherapy
- Intraoperative Guidance & Robotics
- Ivd
- Long-Term Outcome Prediction
- Medication Management
- Medication Reminders
- Mental Health & Support Systems
- Motion Synchronization & Auto Contouring
- Other Administrative Functions
- Other Deep Learning Tools
- Other Diagnosis & Early Detection Functions
- Other Healthcare Providers
- Other Machine Learning Tools
- Other ML Tools
- Other Patient Engagement & Remote Monitoring Functions
- Other Pharmacological Therapy Functions
- Other Pharmacy Management Functions
- Other Radiation Therapy Functions
- Other Treatment Planning & Personalization Functions
- Patient Education & Empowerment
- Patient Eligibility & Authorization
- Patient Registration & Scheduling
- Pattern & Image Recognition
- Personalized Treatment Planning
- Pharmacies
- Pharmacological Therapy
- Pharmacy Audit & Analysis
- Physical Context
- Postoperative Analysis & Recovery
- Pre-Screening
- Precision Medicine & Genomic Analysis
- Predictive Models For Treatment Response
- Preoperative Imaging & 3D Modeling
- Private Payers
- Progress Monitoring & Feedback
- Public Payers
- Radiation Therapy
- Real-Time Adaptive Treatment Delivery
- Real-Time Patient Data Monitoring
- Recurrence Monitoring
- Recurrent Neural Networks (Rnn)
- Reinforcement Learning
- Relapse Prediction & Long-Term Management
- Response & Side-Effect Prediction
- Response Assessment & Quality Assurance
- Risk Assessment & Patient Stratification
- Sentiment Analysis
- Speech Recognition
- Supervised Learning
- Supply Chain & Inventory Management
- Surgical Therapy
- Symptom Management & Virtual Assistance
- Telehealth & Remote Patient Monitoring
- Text Analytics
- Treatment Recommendation Systems
- Unsupervised Learning
- User Context
- Virtual Counseling & Chatbots
- Workforce Management
By Technology
- Clinical Chemistry
- Immunoassays
- Molecular Diagnostics
By Application
- Biomarker Discovery & Analysis
- Clinical Applications
- Disease Interpretation & Report Analysis
- Image Analysis & Interpretation
- Image Captioning & Annotation
- Image Reconstruction
- Non-Clinical Applications
- Other Diagnostic Imaging Applications
- Other Ivd Applications
By Modality
- Computed Tomography (Ct)
- Magnetic Resonance Imaging (Mri)
- Nuclear Imaging (Pet & Spect)
- Other Diagnostic Imaging Modalities
- Ultrasound
- X-Ray Imaging
By Deployment Model
- Cloud-Based Models
- Hybrid Models
- On-Premise Models
By Tool
- Computer Vision
- Context-Aware Computing
- Generative AI
- Image Analysis
- Machine Learning (ML)
- Natural Language Processing (Nlp)
By End User
- Healthcare Payers
- Healthcare Providers
- Other End Users
- Patients
Target Audience
- Healthcare IT Executives : US hospital CIOs and health system IT leaders need this data to evaluate AI technology investments, benchmark against peer institutions, and develop digital transformation roadmaps aligned with market trends and competitive positioning.
- AI Healthcare Vendors : Software companies and AI solution providers targeting the US healthcare market require detailed market sizing, segment analysis, and competitive intelligence to refine go-to-market strategies and identify high-growth opportunities.
- Healthcare Investors : Venture capital firms, private equity investors, and healthcare-focused investment funds need comprehensive US market data to evaluate investment opportunities, assess portfolio company growth potential, and identify emerging market trends.
- Pharmaceutical & Biotech Companies : US drug manufacturers and biotech firms need AI market insights to understand drug discovery acceleration opportunities, evaluate AI platform partnerships, and optimize R&D spending in the rapidly evolving US healthcare innovation ecosystem.
- Healthcare Consultants & Analysts : Management consulting firms and healthcare research organizations require detailed US market data to support client advisory work, competitive analysis, and strategic planning initiatives across hospital networks and health systems.
Key Companies in the US Artificial Intelligence (AI) in Healthcare Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| EPAM SYSTEMS, INC. | United States | ||
| SIEMENS AG | Germany | ||
| WNS GLOBAL SERVICES | India | ||
| L&T TECHNOLOGY SERVICES LIMITED | India | ||
| LARSEN & TOUBRO INFOTECH LIMITED | India | ||
| SOPRA STERIA | United States | ||
| CYIENT | India |
EPAM SYSTEMS, INC.
EPAM Systems, Inc. is a leading digital transformation and software engineering services company headquartered in the United States. The company provides consulting, software development, and IT services to clients across various industries globally.
SIEMENS AG
Siemens AG is a German multinational conglomerate providing automation, digitalization, and electrification solutions across industrial, infrastructure, and mobility sectors worldwide.
WNS GLOBAL SERVICES
WNS Global Services is an India-based business process management and IT services company offering customer engagement, finance and accounting, and technology solutions to global enterprises.
L&T TECHNOLOGY SERVICES LIMITED
L&T Technology Services Limited is an India-based engineering and technology services company providing design, engineering, and digital transformation solutions across multiple industries.
LARSEN & TOUBRO INFOTECH LIMITED
Larsen & Toubro Infotech Limited is an India-based IT services and consulting company offering digital transformation, cloud, and enterprise solutions to global clients.
SOPRA STERIA
Sopra Steria is a digital services and software company providing consulting, systems integration, and software development services, with operations in the United States and globally.
CYIENT
Cyient is an India-based engineering and technology services company specializing in digital, engineering, and cloud solutions for aerospace, defense, and industrial sectors.
Reasons to Buy this Report
- Comprehensive US Market Sizing : Access precise market valuation data specific to the US market, including 2025 baseline ($8.65B) and 2030 forecasts ($43.3B), enabling accurate financial planning and investment decisions tailored to the American healthcare landscape.
- Segment-Specific Insights : Gain detailed analysis of key US healthcare AI segments including diagnostic imaging, clinical decision support, drug discovery, and administrative automation, with segment-level growth projections and adoption trends specific to US providers.
- Competitive Landscape Analysis : Understand the competitive dynamics among US-based and international AI healthcare vendors, including market share distribution, strategic partnerships, and differentiation strategies relevant to the American healthcare market.
- Regulatory and Reimbursement Insights : Receive detailed analysis of US-specific regulatory frameworks, FDA approval pathways, CMS reimbursement policies, and compliance requirements that directly impact AI healthcare solution adoption and market growth in the United States.
- Strategic Growth Opportunities : Identify high-potential market opportunities within the US healthcare system, including underserved specialties, emerging use cases, geographic expansion opportunities, and partnership strategies for maximizing market penetration and revenue growth.
Frequently asked questions
What is the current size of the US AI in healthcare market?
The US AI in healthcare market is valued at $21.63 billion in 2025 and is expected to grow to $110.61 billion by 2030.
What is the projected growth rate for the US AI healthcare market?
The US AI in healthcare market is projected to grow at a compound annual growth rate (CAGR) of 38.6% from 2025 to 2030.
Which AI applications are driving growth in the US healthcare market?
Key applications include diagnostic imaging analysis, clinical decision support systems, drug discovery acceleration, administrative automation, and precision medicine personalization.
What factors are accelerating AI adoption in the US healthcare sector?
Factors include regulatory support, substantial R&D investments, presence of leading tech and healthcare companies, access to venture capital, and the need to address workforce shortages and reduce operational costs.
How is the US positioned compared to other regions in AI healthcare innovation?
The US maintains a competitive advantage through its robust innovation ecosystem, early adoption of emerging technologies, significant capital availability, and leadership in precision medicine and personalized treatment planning.
RESEARCH METHODOLOGY
The study involved significant efforts to estimate the current size of the artificial intelligence (AI) in healthcare market. Exhaustive secondary research was conducted to collect information on the artificial intelligence (AI) in healthcare market. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the artificial intelligence (AI) in healthcare market.
Secondary Research
This research study involved the extensive use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and Companies House documents; investor presentations; and companies' SEC filings. The market for companies offering artificial intelligence (AI) in healthcare solutions is derived from secondary data available through paid and unpaid sources, analysis of the product portfolios of major companies in the ecosystem, and ratings of companies based on performance and quality. Various sources were consulted during the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, company investor presentations, white papers, journals, certified publications, articles by recognized authors, directories, and databases.
Various secondary sources were consulted during the secondary research process to identify and collect information relevant to the study. These sources included annual reports, press releases, investor presentations of artificial intelligence (AI) in healthcare vendors, forums, certified publications, and whitepapers. Secondary research was used to obtain critical information on the industry’s value chain, the pool of key players, market classification, and segmentation from market- and technology-oriented perspectives.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess prospects.
Primary research was conducted to identify segmentation types, key players, and key market dynamics, including drivers, restraints, opportunities, challenges, and strategies adopted by key players.
After the complete market engineering (calculations for market statistics, market breakdown, market size estimates, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers derived.
In the complete market engineering process, top-down and bottom-up approaches, along with several data triangulation methods, were extensively used to perform market estimation and forecasting across the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analyses were conducted on the complete market engineering process to identify key information/insights throughout the report.
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by offering, function, application, deployment, tool, end user, and region).
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and obtain the exact statistics for each market segment and subsegment, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the artificial intelligence (AI) in healthcare market.
Market Definition
The artificial intelligence (AI) in healthcare market encompasses the application of AI technologies, such as machine learning, natural language processing, computer vision, and robotics, to improve healthcare delivery, enhance operational efficiency, and provide personalized care. These solutions address a wide range of use cases, including diagnostic imaging, predictive analytics, drug discovery, patient engagement, remote monitoring, and administrative workflows, enabling healthcare providers, payers, and pharmaceutical companies to drive innovation and improve outcomes.
Key Stakeholders
- Artificial intelligence (AI) in healthcare software vendors
- Artificial intelligence (AI) in healthcare service providers
- Independent software vendors (ISVs)
- Platform providers
- Technology providers
- System integrators
- Cloud service providers
- Healthcare IT service providers
- Hospitals and surgical centers
- Diagnostic imaging centers
- Academic institutes and research laboratories
- Forums, alliances, and associations
- Government organizations
- Institutional investors and investment banks
- Investors/Shareholders
- Venture capitalists
- Research and consulting firms
Report Objectives
- To define, describe, and forecast the global artificial intelligence (AI) in healthcare market based on offering, function, application, deployment, tool, end user, and region
- To provide detailed information regarding the factors influencing the growth of the market (such as the drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall artificial intelligence (AI) in healthcare market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the artificial intelligence (AI) in healthcare market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies in the market
- To track and analyze competitive developments such as product & service launches; expansions; partnerships, agreements, and collaborations; and acquisitions in the artificial intelligence (AI) in healthcare market
- To benchmark players within the artificial intelligence (AI) in healthcare market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Europe artificial intelligence (AI) in healthcare market into Denmark, Norway, and others
- Further breakdown of the Rest of Asia Pacific artificial intelligence (AI) in healthcare market into Vietnam, New Zealand, Australia, South Korea, and others
Get the Full Artificial Intelligence (AI) in Healthcare Market Report
Full forecast, segment splits, and company analysis for all Artificial Intelligence (AI) in Healthcare Market.
- Canada Artificial Intelligence (AI) in Healthcare Market
- Germany Artificial Intelligence (AI) in Healthcare Market
- UK Artificial Intelligence (AI) in Healthcare Market
- France Artificial Intelligence (AI) in Healthcare Market
- Italy Artificial Intelligence (AI) in Healthcare Market
- Spain Artificial Intelligence (AI) in Healthcare Market
- China Artificial Intelligence (AI) in Healthcare Market
- Japan Artificial Intelligence (AI) in Healthcare Market
- India Artificial Intelligence (AI) in Healthcare Market
- Brazil Artificial Intelligence (AI) in Healthcare Market
- Mexico Artificial Intelligence (AI) in Healthcare Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report